About this trial
In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.
Eligibility criteria
Qualifiers
Person presenting to emergencies for psychiatric reasons
Adult person
Free and informed consent signed
Person speaking and writing French fluently
Disqualifiers
Neurological disorders or major cognitive deterioration: presence of confusion
Acute psychotic decompensation
Troubled acute behavior
Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment
Trial design
Treatments tested in this trial
- Implicit Attitude Test
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Centre Hospitalier Pinel d'Amiens
Collaborator